A Company Committed
to Curing Cancer
Alpha2 Pharmaceuticals is dedicated to curing cancer, through the discovery and development of new drugs and immunotherapies. We leverage the rapid translational capabilities of a commercial platform to discover, develop and launch innovative scientific discoveries already available from its academic laboratories, while continuing to develop a robust R&D platform for pipeline development.
Led by some of America's top oncologists, Rod D. Martin is pleased to be a Co-Founder and serve as Vice Chairman of the Board of Directors.